Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5854270 | SANDOZ | Oral compositions containing ondansetron |
Nov, 2015
(8 years ago) | |
US5854270 (Pediatric) | SANDOZ | Oral compositions containing ondansetron |
May, 2016
(7 years ago) |
Market Authorisation Date: 24 January, 1997
Treatment: Relief of nausea and vomiting
Dosage: SOLUTION;ORAL